Table 2.
Molecules | Relative Change (%) |
---|---|
Concentration increased after RIPC | |
3‐Methylhistidine*** | 7.8 |
Cystine*** | 6.0 |
Kynurenine*** | 5.9 |
Arginine*** | 5.3 |
Serine*** | 3.1 |
AABU*** | 2.5 |
1‐Methylhistidine** | 8.4 |
Glutamate* | 5.2 |
Glycine* | 2.3 |
Concentration decreased after RIPC | |
Aspartate*** | −9.2 |
Ornithine*** | −4.7 |
Tyrosine*** | −3.7 |
Phenylalanine*** | −3.4 |
Tryptophan*** | −3.4 |
Citrulline*** | −3.2 |
Isoleucine** | −1.9 |
Sarcosine* | −25.8 |
Valine* | −1.2 |
AABU indicates α‐aminobutyric acid.
Only metabolite concentrations that varied significantly after remote ischemic preconditioning (RIPC), according to Student t test for paired samples, are displayed. The relative changes (in %) were calculated as 100×(Concentration after RIPC−Concentration before RIPC)/Concentration before RIPC (***P<0.01, **P<0.05, *P<0.08).